Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endocyte Inc (NASDAQ:ECYT)

3.90
Delayed Data
As of Apr 29
 -0.17 / -4.18%
Today’s Change
2.65
Today|||52-Week Range
6.35
-2.74%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Middleton Fred A
Director
Buy1/15/201620,000$2.80$56.0K+33.11%
Middleton Fred A
Director
Buy1/19/201610,000$2.79$27.9K+38.30%
Low Philip S
Chief Scientific Officer
Buy12/24/201513,089$1.91$25.0K-6.70%
Leamon Christopher P
Vice President-Research
Buy2/17/201613,089$1.91$25.0K+18.90%
Ellis P Ron
President & Chief Executive Officer
Sale2/04/20163,320$3.18$10.6K+22.64%
Ellis P Ron
President & Chief Executive Officer
Sale2/06/20162,085$3.02$6.3K+38.30%
Sherman Michael A
Chief Operating & Financial Officer
Sale2/04/20161,771$3.18$5.6K+22.64%
Leamon Christopher P
Vice President-Research
Sale2/04/20161,081$3.18$3.4K+22.64%
Low Philip S
Chief Scientific Officer
Sale2/04/20161,081$3.18$3.4K+22.64%
Harper Scot L
Vice President-Clinical Operations
Sale2/04/20161,078$3.18$3.4K+22.64%
Page of 4